CIBC Bancorp USA Inc. Takes $29.65 Million Position in Lam Research Corporation $LRCX

CIBC Bancorp USA Inc. bought a new stake in shares of Lam Research Corporation (NASDAQ:LRCX) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 221,433 shares of the semiconductor company’s stock, valued at approximately $29,650,000.

Several other large investors have also added to or reduced their stakes in the business. Stance Capital LLC bought a new stake in Lam Research in the third quarter worth approximately $26,000. Howard Hughes Medical Institute bought a new position in shares of Lam Research during the 2nd quarter worth approximately $27,000. Triumph Capital Management acquired a new stake in shares of Lam Research during the 3rd quarter worth approximately $27,000. Strategic Wealth Investment Group LLC acquired a new stake in shares of Lam Research during the 2nd quarter worth approximately $29,000. Finally, Delos Wealth Advisors LLC bought a new stake in shares of Lam Research in the 2nd quarter valued at $30,000. Institutional investors and hedge funds own 84.61% of the company’s stock.

Lam Research Stock Performance

Shares of LRCX stock opened at $224.71 on Thursday. The company has a current ratio of 2.26, a quick ratio of 1.61 and a debt-to-equity ratio of 0.37. The firm has a fifty day simple moving average of $226.06 and a two-hundred day simple moving average of $175.71. Lam Research Corporation has a 12 month low of $56.32 and a 12 month high of $256.68. The firm has a market capitalization of $280.61 billion, a PE ratio of 46.05, a price-to-earnings-growth ratio of 2.44 and a beta of 1.77.

Lam Research (NASDAQ:LRCX) last released its quarterly earnings data on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share for the quarter, beating analysts’ consensus estimates of $1.17 by $0.10. The firm had revenue of $5.34 billion for the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The business’s quarterly revenue was up 22.1% compared to the same quarter last year. During the same period last year, the firm earned $0.91 earnings per share. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Analysts forecast that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 8th. Investors of record on Wednesday, March 4th will be given a $0.26 dividend. The ex-dividend date of this dividend is Wednesday, March 4th. This represents a $1.04 annualized dividend and a yield of 0.5%. Lam Research’s dividend payout ratio (DPR) is presently 21.31%.

Insider Activity at Lam Research

In other Lam Research news, CFO Douglas R. Bettinger sold 50,057 shares of Lam Research stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $224.03, for a total transaction of $11,214,269.71. Following the completion of the transaction, the chief financial officer owned 1,081,705 shares in the company, valued at approximately $242,334,371.15. The trade was a 4.42% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Eric Brandt sold 35,000 shares of the business’s stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $225.60, for a total value of $7,896,000.00. Following the sale, the director directly owned 253,705 shares of the company’s stock, valued at $57,235,848. This represents a 12.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 130,886 shares of company stock valued at $29,658,802. 0.31% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. New Street Research boosted their target price on shares of Lam Research from $195.00 to $235.00 and gave the company a “neutral” rating in a research report on Friday, January 30th. Evercore set a $275.00 price target on shares of Lam Research in a research note on Thursday, January 29th. Royal Bank Of Canada reiterated an “outperform” rating and set a $290.00 price objective (up from $260.00) on shares of Lam Research in a report on Thursday, January 29th. Susquehanna set a $325.00 price objective on shares of Lam Research and gave the stock a “positive” rating in a research report on Thursday, January 29th. Finally, B. Riley Financial restated a “buy” rating on shares of Lam Research in a research note on Thursday, January 15th. One research analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $245.35.

Lam Research Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.